...
首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
【24h】

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma

机译:肾脏肾透明细胞癌的预后和转移性剪接特征的鉴定

获取原文

摘要

Background: Kidney renal clear cell carcinoma (KIRC) is the malignancy originated from the renal epithelium, with a high rate of distant metastasis. Aberrant alternative splicing (AS) of pre-mRNA are widely reported to be involved in the tumorigenesis and metastasis of multiple cancers. The aim of this study is to explore the mechanism of alternative splicing events (ASEs) underlying tumorigenesis and metastasis of KIRC. Methods: RNA-seq of 537 KIRC samples downloaded from the TCGA database and ASEs data from the TCGASpliceSeq database were used to identify ASEs in patients with KIRC. The univariate and Lasso regression analysis were used to screen the most significant overall survival-related ASEs (OS-SEs). Based on those, the OS-SEs model was proposed. The interaction network of OS-SEs and splicing factors (SFs) with absolute value of correlation coefficient value 0.750 was constructed by Pearson correlation analysis. The OS-SEs significantly related to distant metastasis and clinical stage were identified by non-parametric test, and those were also integrated into co-expression analysis with prognosis-related Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways identified by Gene Set Variation Analysis (GSVA). ASEs with significance were selected for multiple online database validation. Results: A total of prognostic 6,081 overall survival-related ASEs (OS-SEs) were identified by univariate Cox regression analysis and a prediction model was constructed based on 5 OS-SEs screened by Lasso regression with the Area Under Curve of 0.788. Its risk score was also illustrated to be an independent predictor, which the good reliability of the model. Among 390 identified candidate SFs, DExD-Box Helicase 39B (DDX39B) was significantly correlated with OS and metastasis. After external database validation, Retained Intron of Ras Homolog Family Member T2 (RHOT2) and T-Cell Immune Regulator 1 (TCIRG1) were identified. In the co-expression analysis, overlapped co-expression signal pathways for RHOT2 and TCIRG1 were sphingolipid metabolism and N-glycan biosynthesis. Conclusions: Based on the results of comprehensive bioinformatic analysis, we proposed that aberrant DDX39B regulated RHOT2-32938-RI and TCIRG1-17288-RI might be associated with the tumorigenesis, metastasis and poor prognosis of KIRC via sphingolipid metabolism or N-glycan biosynthesis pathway.
机译:背景:肾脏肾透明细胞癌(KIRC)是起源于肾上皮的恶性肿瘤,远处转移率很高。广泛报道pre-mRNA的异常替代剪接(AS)参与多种癌症的发生和转移。这项研究的目的是探讨潜在的KIRC肿瘤发生和转移的剪接事件(ASE)的机制。方法:使用从TCGA数据库下载的537个KIRC样品的RNA-seq和从TCGASpliceSeq数据库中获得的ASEs数据,鉴定KIRC患者的ASEs。使用单变量和套索回归分析来筛选最显着的总体生存相关ASE(OS-SE)。在此基础上,提出了OS-SEs模型。通过Pearson相关分析,建立了OS-SE与剪接因子(SFs)之间的相互作用网络,相关系数的绝对值大于0.750。通过非参数测试确定了与远处转移和临床分期显着相关的OS-SE,并将这些OS-SEs与通过基因组变异分析确定的与预后相关的《京都基因与基因组百科全书》(KEGG)途径整合到共表达分析中(GSVA)。选择具有重要意义的ASE进行多个在线数据库验证。结果:通过单变量Cox回归分析确定了总共6,081例预后与生存有关的ASE(OS-SEs),并基于5套OS-SE(通过Lasso回归筛选,曲线下面积为0.788)构建了预测模型。它的风险评分也被说明是一个独立的预测变量,它具有模型的良好可靠性。在390个已确定的候选SF中,DExD-Box解旋酶39B(DDX39B)与OS和转移密切相关。外部数据库验证后,确定了Ras同源家族成员T2(RHOT2)和T细胞免疫调节剂1(TCIRG1)的内含子。在共表达分析中,RHOT2和TCIRG1的重叠共表达信号途径是鞘脂代谢和N-聚糖生物合成。结论:基于全面的生物信息学分析结果,我们提出DDX39B异常调控的RHOT2-32938-RI和TCIRG1-17288-RI可能通过鞘脂代谢或N-聚糖生物合成途径与KIRC的发生,转移和不良预后有关。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号